These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 712662)

  • 1. Relationship between the radiation dose and chromosome aberrations in atomic bomb survivors of Hiroshima and Nagasaki.
    Awa AA; Sofuni T; Honda T; Itoh M; Neriishi S; Otake M
    J Radiat Res; 1978 Jun; 19(2):126-40. PubMed ID: 712662
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose-response relationship of neutron and gamma rays to chromosomally aberrant cells among atomic bomb survivors in Hiroshima and Nagasaki.
    Otake M
    J Radiat Res; 1979 Dec; 20(4):307-21. PubMed ID: 536952
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytogenetic validation of DS02R1-estimated dose for atomic bomb survivors in Hiroshima and Nagasaki with FISH.
    Kodama Y; Nakamura N; Nakano M; Ohtaki K; Hamasaki K; Noda A
    Int J Radiat Biol; 2024; 100(8):1155-1164. PubMed ID: 38991111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent chromosome aberrations in the somatic cells of A-bomb survivors, Hiroshima and Nagasaki.
    Awa AA
    J Radiat Res; 1991 Mar; 32 Suppl():265-74. PubMed ID: 1762114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective dose of A-bomb radiation in Hiroshima and Nagasaki as assessed by chromosomal effectiveness of spectrum energy photons and neutrons.
    Sasaki MS; Endo S; Ejima Y; Saito I; Okamura K; Oka Y; Hoshi M
    Radiat Environ Biophys; 2006 Jul; 45(2):79-91. PubMed ID: 16807767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Review of 30 years study of Hiroshima and Nagasaki atomic bomb survivors. The Japan Radiation Research Society Chiba. Japan, September, 1975].
    Gus'kova AK; Sadchikova EN
    Med Radiol (Mosk); 1977 Aug; 22(8):69-77. PubMed ID: 927066
    [No Abstract]   [Full Text] [Related]  

  • 7. Stable chromosome aberrations in atomic bomb survivors: results from 25 years of investigation.
    Kodama Y; Pawel D; Nakamura N; Preston D; Honda T; Itoh M; Nakano M; Ohtaki K; Funamoto S; Awa AA
    Radiat Res; 2001 Oct; 156(4):337-46. PubMed ID: 11554845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New dosimetry of atomic bomb radiations.
    Fry RJ; Sinclair WK
    Lancet; 1987 Oct; 2(8563):845-8. PubMed ID: 2889042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of new Hiroshima and Nagasaki dose estimates: cancer risks and neutron RBE.
    Straume T; Dobson RL
    Health Phys; 1981 Oct; 41(4):666-71. PubMed ID: 7309524
    [No Abstract]   [Full Text] [Related]  

  • 10. Review of thirty years study of Hiroshima and Nagasaki atomic bomb survivors. II. Biological effects. G. Chromosome aberrations in somatic cells.
    Awa AA
    J Radiat Res; 1975 Sep; 16 Suppl():122-31. PubMed ID: 1195195
    [No Abstract]   [Full Text] [Related]  

  • 11. Stable chromosome aberrations among A-bomb survivors: an update.
    Stram DO; Sposto R; Preston D; Abrahamson S; Honda T; Awa AA
    Radiat Res; 1993 Oct; 136(1):29-36. PubMed ID: 8210335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-response relationship of neutrons and gamma rays to leukemia incidence among atomic bomb survivors in Hiroshima and Nagasaki by type of leukemia, 1950--1971.
    Ishimaru T; Otake M; Ischimaru M
    Radiat Res; 1979 Feb; 77(2):377-94. PubMed ID: 286375
    [No Abstract]   [Full Text] [Related]  

  • 13. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Chromosome abnormality in early entrants.
    Kamada N
    J Radiat Res; 1991 Mar; 32 Suppl():275-7. PubMed ID: 1762115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of chromosome aberrations in atomic bomb survivors for dose assessment: studies at the Radiation Effects Research Foundation from 1968 to 1993.
    Awa A
    Stem Cells; 1997; 15 Suppl 2():163-73. PubMed ID: 9368301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki, 1950-69.
    McGregor H; Land CE; Choi K; Tokuoka S; Liu PI; Wakabayashi T; Beebe GW
    J Natl Cancer Inst; 1977 Sep; 59(3):799-811. PubMed ID: 894745
    [No Abstract]   [Full Text] [Related]  

  • 16. Mean bone marrow dose of atomic bomb survivors in Hiroshima and Nagasaki.
    Hashizume T; Maruyama T; Nishizawa K; Fukuhisa K
    J Radiat Res; 1977 Mar; 18(1):67-83. PubMed ID: 853474
    [No Abstract]   [Full Text] [Related]  

  • 17. Choice of model and uncertainties of the gamma-ray and neutron dosimetry in relation to the chromosome aberrations data in Hiroshima and Nagasaki.
    Rühm W; Walsh L; Chomentowski M
    Radiat Environ Biophys; 2003 Jul; 42(2):119-28. PubMed ID: 12844221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The F value for chromosome aberrations in atomic bomb survivors does not provide evidence for a primary contribution of neutrons to the dose in Hiroshima.
    Kodama Y; Ohtaki K; Awa AA; Nakano M; Itoh M; Nakamura N
    Radiat Res; 1999 Nov; 152(5):558-62. PubMed ID: 10521934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comments on "Direct biological evidence for a significant neutron dose to survivors of the Hiroshima atomic bomb" by D.J. Brenner (Radiat. Res. 145, 501-507, 1996).
    Schmid E; Bauchinger M
    Radiat Res; 1996 Oct; 146(4):479-82. PubMed ID: 8927721
    [No Abstract]   [Full Text] [Related]  

  • 20. Estimation of whole-body doses by means of chromosome aberrations observed in survivors of the Hiroshima A-bomb.
    Randolph ML; Brewen JG
    Radiat Res; 1980 May; 82(2):393-407. PubMed ID: 7375639
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.